Browsing by Funding agency "CB16/12/00480"
Now showing items 1-1 of 1
-
Article
Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation
(Springer Nature, 2020)This multicenter phase I trial was designed to evaluate the safety and efficacy of bortezomib (Bz) as part of both the ...